Stock Movers: United Health Sinks, Eli Lilly Soars on Drug Trial, Hertz Gains

United Health Earnings Miss

• 📉 United Health is down significantly after cutting its full-year adjusted EPS forecast and missing first-quarter earnings estimates.
• ⚠️ The company cited heightened care needs in Medicare and unexpected changes in its Optum Health business as reasons for the shortfall.
• 📊 United Health revised its 2025 adjusted earnings forecast downwards, but stated that the issues are "highly addressable" for 2025 and 2026.
• 💥 This news has impacted other health insurers, with Humana, CVS, and Sigma also experiencing notable stock declines.

Hertz Stock Surges on Investment News

• 🚀 Hertz shares are continuing to rise, extending yesterday's record gains.
• 📌 This surge follows a report that Pershing Square Capital Management has acquired a nearly 20% stake in the car rental company.
• 💼 Pershing Square's investment makes it the second-largest shareholder, signaling strong investor confidence.
• 🛠️ Hertz has been working to revamp its fleet, including addressing challenges with its investment in Tesla electric vehicles.

Eli Lilly's Drug Trial Success

• ✨ Eli Lilly shares are soaring after its drug, orforglipron, successfully completed a Phase 3 trial.
• 💊 This marks the first small molecule GLP-1 drug to achieve this milestone, demonstrating statistically significant efficacy.
• ⚖️ Participants on the highest dose lost an average of 16 pounds, with safety profiles consistent with injectable GLP-1s.
• 📉 Competitor Viking Therapeutics saw its stock fall as Eli Lilly's positive trial results were announced.

Alcoa Faces Tariff Costs

• ⚠️ Alcoa, the largest US aluminum producer, reported a decline in shares due to tariff-related costs.
• 💰 The company expects to incur $20 million in losses from duties on imports from Canada.
• 📈 Alcoa anticipates these tariff costs to increase by $90 million in the second quarter, highlighting the impact of trade policies on US companies.